Involvement of a cis-acting element in the suppression of carbamoyl phosphate synthetase I gene expression in the liver of carnitine-deficient mice

Molecular Genetics and Metabolism

Volumn 68, Issue 3, 1999, Pages 346-356

  Abdullah Abu Musa, Dewan Md ^a   Kobayashi, Keiko ^a   Yasuda, Izumi ^a   Iijima, Mikio ^a   Christoffels, Vincent M ^b   Tomomura, Mineko ^a   Horiuchi, Masahisa ^a   Ohnishi, Tomokazu ^a   Kajihara, Takehiro ^a   Daikuhara, Yasushi ^a   Lamers, Wouter H ^b   Saheki, Takeyori ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Activator protein 1 (AP 1); Carbamoylphosphate synthetase I (CPS); Carnitine deficiency; Hyperammonemia; Juvenile visceral steatosis (JVS)

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE; CARNITINE; CHLORAMPHENICOL ACETYLTRANSFERASE; CIS ACTING ELEMENT; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; LIVER ENZYME; LUCIFERASE; OLEIC ACID; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARNITINE DEFICIENCY; CONTROLLED STUDY; ENHANCER REGION; FEMALE; GENE CONSTRUCT; GENE REPRESSION; HORMONE RESPONSE; HYPERAMMONEMIA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RAT; STARVATION; STEATOSIS; TRANSGENE; TRANSGENIC MOUSE;

EID: 0344286177     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2905     Document Type: Article

References (42)

1. Kuwajima M, Kono N, Horiuchi M, Imamura Y, Ono A, Inui Y, Kawata S, Koizumi T, Hayakawa J, Saheki T, Tarui S. Animal model of systemic carnitine deficiency: analysis in C3H-H-2° strain of mouse associated with juvenile visceral steatosis. Biochem Biophys Res Commun. 174:1991;1090-1094.
2. Horiuchi M, Kobayashi K, Tomomura M, Kuwajima M, Imamura Y, Koizumi T, Nikaido H, Hayakawa J, Saheki T. Carnitine administration to juvenile visceral steatosis mice corrects the suppressed expression of urea cycle enzymes by normalizing their transcription. J Biol Chem. 267:1992;5032-5035.
3. Koizumi T, Nikaido H, Hayakawa J, Nonomura A, Yoneda T. Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2° strain of mouse with similarities to Reye's syndrome. Lab Anim. 22:1988;83-87.
4. Horiuchi M, Yoshida H, Kobayashi K, Kuriwaki K, Yoshimine K, Tomomura M, Koizumi T, Nikaido H, Hayakawa J, Kuwajima M, Saheki T. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett. 326:1993;267-271.
5. Tomomura M, Imamura Y, Horiuchi M, Koizumi T, Nikaido H, Hayakawa J, Saheki T. Abnormal expression of urea cycle enzyme genes in juvenile visceral steatosis (jvs) mice. Biochim Biophys Acta. 1138:1992;167-171.
6. Tomomura M, Imamura Y, Tomomura A, Horiuchi M, Saheki T. Abnormal gene expression and regulation in the liver of jvs mice with systemic carnitine deficiency. Biochim Biophys Acta. 1226:1994;307-314.
7. Tomomura M, Nakagawa K, Saheki T. Proto-oncogene c-jun and c-fos messenger RNAs increase in the liver of carnitine-deficient juvenile visceral steatosis (jvs) mice. FEBS Lett. 311:1992;63-66.
8. Tomomura M, Tomomura A, Musa D MAA, Horiuchi M, Takiguchi M, Mori M, Saheki T. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood. J Biochem. 121:1997;172-177.
9. Takiguchi M, Mori M. Transcriptional regulation of genes for ornithine cycle enzymes. Biochem J. 312:1995;649-659.
10. Saheki T, Tomomura M, Horiuchi M, Imamura Y, Tomomura A, Musa D MAA, Kobayashi K. Abnormal gene expression causing hyperammonemia in carnitine-deficient juvenile visceral steatosis (JVS) mice. Felipo V Grisolia S. Advances in Cirrhosis, Hyperammonemia, and Hepatic Encephalopathy. 1997;159-172 Plenum Press, New York.
11. Tomomura M, Tomomura A, Musa D MAA, Saheki T. Long-chain fatty acids suppress the induction of urea cycle enzyme genes by glucocorticoid action. FEBS Lett. 399:1996;310-312.
12. Yang-Yen H-F, Chambard J-C, Sun Y-L, Smeal T, Schmidt T J, Drouin J, Karin M. Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 62:1990;1205-1215.
13. Jonat C, Rahmsdorf H J, Park K-K, Cato A CB, Gebel S, Ponta H, Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 62:1990;1189-1204.
14. Schüle R, Rangarajan P, Kliewer S, Ransone L J, Bolado J, Yang N, Verma I M, Evans R M. Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell. 62:1990;1217-1226.
15. Hotta K, Kuwajima M, Ono A, Nakajima H, Horikawa Y, Miyagawa J, Namba M, Hanafusa T, Horiuchi M, Nikaido H, Hayakawa J, Saheki T, Kono N, Noguchi T, Matsuzawa Y. Disordered expression of glycolytic and gluconeogenic liver enzymes of juvenile visceral steatosis mice with systemic carnitine deficiency. Diabetes Res Clin Pract. 32:1996;117-123.
16. Christoffels V M, van den Hoff M JB, Lamers M C, van Roon M A, de Boer P AJ, Moorman A FM, Lamers W H. The upstream regulatory region of the carbamoyl-phosphate synthetase I gene controls its tissue-specific, developmental, and hormonal regulation in vivo. J Biol Chem. 271:1996;31243-31250.
17. Nyunoya H, Broglie K E, Widgren E E, Lusty C J. Characterization and derivation of the gene coding for mitochondrial carbamyl phosphate synthetase I of rat. J Biol Chem. 260:1985;9346-9356.
18. Lagacé M, Howell B W, Burak R, Lusty C J, Shore G C. Rat carbamyl-phosphate synthetase I gene: promoter sequence and tissue-specific transcriptional regulation in vitro. J Biol Chem. 262:1987;10415-10418.
19. van den Hoff M JB, van de Zande L PWGM, Dingemanse M A, Das A T, Labruyère W, Moorman A FM, Charles R, Lamers W H. Isolation and characterization of the rat gene for carbamoyl phosphate synthetase I. Eur J Biochem. 228:1995;351-361.
20. Nikaido H, Horiuchi M, Hashimoto N, Saheki T, Hayakawa J. Mapping of jvs (juvenile visceral steatosis) gene, which causes systemic carnitine deficiency in mice, on chromosome 11. Mamm Genome. 6:1995;369-370.
21. Qi S-L, Akagi K, Araki K, Miyazaki J, Yamamura K. Rapid identification of transgenic mice with PCR amplification of DNA from ear punching. Methods Mol Cell Biol. 2:1991;119-122.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
23. Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
24. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, New York.
25. Christoffels V M, van den Hoff M JB, Moorman A FM, Lamers W H. The far-upstream enhancer of the carbamoyl-phosphate synthetase I gene is responsible for the tissue specificity and hormone inducibility of its expression. J Biol Chem. 270:1995;24932-24940.
26. Higuchi R. DNA engineering using PCR in PCR Technology: Principles and Application for DNA Amplification. Enrlich H A, Katoh I. Takara Syuzou. 1990;87-100.
27. Murakami A, Kitagawa Y, Sugimoto E. Induction of carbamoyl-phosphate synthetase I in Reuber hepatoma H-35 by dexamethasone. Biochim Biophys Acta. 740:1983;38-45.
28. Lamers W H, Zonneveld D, Charles R. Inducibility of carbamoyl phosphate synthetase (ammonia) in cultures of embryonic hepatocytes: ontogenesis of the responsiveness to hormones. Dev Biol. 105:1984;500-508.
29. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
30. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest. 81:1988;414-419.
31. Lagacé M, Goping I S, Mueller C R, Lazzaro M, Shore G C. The carbamyl phosphate synthetase promoter contains multiple binding sites for C/EBP-related proteins. Gene. 118:1992;231-238.
32. Howell B W, Lagacé M, Shore G C. Activity of the carbamyl phosphate synthetase I promoter in liver nuclear extracts is dependent on a cis-acting C/EBP recognition element. Mol Cell Biol. 9:1989;2928-2933.
33. Goping I S, Shore G C. Interactions between repressor and anti-repressor elements in the carbamyl phosphate synthetase I promoter. J Biol Chem. 269:1994;3891-3896.
34. Simar-Blanchet A E, Legraverend C, Thissen J P, Le Cam A. Transcription of the rat serine protease inhibitor 2. 1 gene in vivo: correlation with GAGA box promoter occupancy and mechanism of cytokine-mediated down-regulation. Mol Endocrinol. 12:1998;391-404.
35. Christoffels V M, Grange T, Kaestner K H, Cole T J, Darlington G J, Croniger C M, Lamers W H. Glucocorticoid receptor, C/EBP, HNF3, and protein kinase A coordinately activate the glucocorticoid response unit of the carbamoyl phosphate synthetase I gene. Mol Cell Biol. 18:1998;6305-6315.
36. Roe C R, Coates P M. Mitochondrial fatty acid oxidation disorders. Scriver CR Beaudet AL, Sly WS Valle D. The Metabolic and Molecular Bases of Inherited Disease. 1995;1501-1533 McGraw-Hill, New York.
37. Pande S V, Murthy M SR. Carnitine-acylcarnitine translocase deficiency: implications in human pathology. Biochim Biophys Acta. 1226:1994;269-276.
38. Vianey-Saban C, Stremler N, Paut O, Buttin T, Divry P, Zabot M T, Camboulives J, Mathieu M, Mousson B. Infantile form of carnitine palmitoyltransferase II deficiency in a girl with rapid fatal onset. J Inher Metab Dis. 18:1995;362-363.
39. Rufini S, Bragetti P, Brunelli B, Campolo G, Lato M. Non-ketotic hypoglycemia caused by carnitine palmitoyltransfease I deficiency. Pediatr Med Chir. 15:1993;63-66.
40. Imamura Y, Saheki T, Arakawa H, Noda T, Koizumi T, Nikaido H, Hayakawa J. Urea cycle disorder in C3H-H-2° mice with juvenile steatosis of viscera. FEBS Lett. 260:1990;119-121.
41. Horiuchi M, Kobayashi K, Yamaguchi S, Shimizu N, Koizumi T, Nikaido H, Hayakawa J, Kuwajima M, Saheki T. Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system. Biochim Biophys Acta. 1226:1994;25-30.
42. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M, Tsuji A. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet. 21:1999;91-94.